These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 25662504)

  • 1. A leak pathway for luminal protons in endosomes drives oncogenic signalling in glioblastoma.
    Kondapalli KC; Llongueras JP; Capilla-González V; Prasad H; Hack A; Smith C; Guerrero-Cázares H; Quiñones-Hinojosa A; Rao R
    Nat Commun; 2015 Feb; 6():6289. PubMed ID: 25662504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells.
    Gomez Zubieta DM; Hamood MA; Beydoun R; Pall AE; Kondapalli KC
    Cell Commun Signal; 2017 Dec; 15(1):55. PubMed ID: 29268774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A gain of function paradox: Targeted therapy for glioblastoma associated with abnormal NHE9 expression.
    Pall AE; Juratli L; Guntur D; Bandyopadhyay K; Kondapalli KC
    J Cell Mol Med; 2019 Nov; 23(11):7859-7872. PubMed ID: 31532058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging links between endosomal pH and cancer.
    Ko M; Quiñones-Hinojosa A; Rao R
    Cancer Metastasis Rev; 2020 Jun; 39(2):519-534. PubMed ID: 32253638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
    Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
    PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting OSMR in glioma stem cells.
    Mohan S; Bonni A; Jahani-Asl A
    Oncotarget; 2017 Mar; 8(10):16103-16104. PubMed ID: 28177884
    [No Abstract]   [Full Text] [Related]  

  • 7. Role of glycosyltransferase PomGnT1 in glioblastoma progression.
    Lan J; Guo P; Lin Y; Mao Q; Guo L; Ge J; Li X; Jiang J; Lin X; Qiu Y
    Neuro Oncol; 2015 Feb; 17(2):211-22. PubMed ID: 25085363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erlotinib resistance in EGFR-amplified glioblastoma cells is associated with upregulation of EGFRvIII and PI3Kp110δ.
    Schulte A; Liffers K; Kathagen A; Riethdorf S; Zapf S; Merlo A; Kolbe K; Westphal M; Lamszus K
    Neuro Oncol; 2013 Oct; 15(10):1289-301. PubMed ID: 23877316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Afatinib and Temozolomide combination inhibits tumorigenesis by targeting EGFRvIII-cMet signaling in glioblastoma cells.
    Vengoji R; Macha MA; Nimmakayala RK; Rachagani S; Siddiqui JA; Mallya K; Gorantla S; Jain M; Ponnusamy MP; Batra SK; Shonka N
    J Exp Clin Cancer Res; 2019 Jun; 38(1):266. PubMed ID: 31215502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The EGFR inhibitor gefitinib suppresses ligand-stimulated endocytosis of EGFR via the early/late endocytic pathway in non-small cell lung cancer cell lines.
    Nishimura Y; Bereczky B; Ono M
    Histochem Cell Biol; 2007 May; 127(5):541-53. PubMed ID: 17361439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fyn and SRC are effectors of oncogenic epidermal growth factor receptor signaling in glioblastoma patients.
    Lu KV; Zhu S; Cvrljevic A; Huang TT; Sarkaria S; Ahkavan D; Dang J; Dinca EB; Plaisier SB; Oderberg I; Lee Y; Chen Z; Caldwell JS; Xie Y; Loo JA; Seligson D; Chakravari A; Lee FY; Weinmann R; Cloughesy TF; Nelson SF; Bergers G; Graeber T; Furnari FB; James CD; Cavenee WK; Johns TG; Mischel PS
    Cancer Res; 2009 Sep; 69(17):6889-98. PubMed ID: 19690143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circular RNA-encoded oncogenic E-cadherin variant promotes glioblastoma tumorigenicity through activation of EGFR-STAT3 signalling.
    Gao X; Xia X; Li F; Zhang M; Zhou H; Wu X; Zhong J; Zhao Z; Zhao K; Liu D; Xiao F; Xu Q; Jiang T; Li B; Cheng SY; Zhang N
    Nat Cell Biol; 2021 Mar; 23(3):278-291. PubMed ID: 33664496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma.
    Li M; Mukasa A; Inda MM; Zhang J; Chin L; Cavenee W; Furnari F
    J Exp Med; 2011 Dec; 208(13):2657-73. PubMed ID: 22162832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid receptor-interacting protein 13 and EGFR form a feedforward loop promoting glioblastoma growth.
    Hu L; Shen D; Liang D; Shi J; Song C; Jiang K; Menglin Ren ; Du S; Cheng W; Ma J; Li S; Bi X; Barr MP; Fang Z; Xu Q; Li W; Piao H; Meng S
    Cancer Lett; 2020 Nov; 493():156-166. PubMed ID: 32860853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitogenic signalling in the absence of epidermal growth factor receptor activation in a human glioblastoma cell line.
    Wang M; Maier P; Wenz F; Giordano FA; Herskind C
    J Neurooncol; 2013 Dec; 115(3):323-31. PubMed ID: 24022637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gefitinib induces EGFR and α5β1 integrin co-endocytosis in glioblastoma cells.
    Blandin AF; Cruz Da Silva E; Mercier MC; Glushonkov O; Didier P; Dedieu S; Schneider C; Devy J; Etienne-Selloum N; Dontenwill M; Choulier L; Lehmann M
    Cell Mol Life Sci; 2021 Mar; 78(6):2949-2962. PubMed ID: 33151388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of multiple ERBB family receptors mediates glioblastoma cancer stem-like cell resistance to EGFR-targeted inhibition.
    Clark PA; Iida M; Treisman DM; Kalluri H; Ezhilan S; Zorniak M; Wheeler DL; Kuo JS
    Neoplasia; 2012 May; 14(5):420-8. PubMed ID: 22745588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The endosomal pH regulator NHE9 is a driver of stemness in glioblastoma.
    Ko M; Makena MR; Schiapparelli P; Suarez-Meade P; Mekile AX; Lal B; Lopez-Bertoni H; Kozielski KL; Green JJ; Laterra J; Quiñones-Hinojosa A; Rao R
    PNAS Nexus; 2022 Mar; 1(1):pgac013. PubMed ID: 35387234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of DYRK1A destabilizes EGFR and reduces EGFR-dependent glioblastoma growth.
    Pozo N; Zahonero C; Fernández P; Liñares JM; Ayuso A; Hagiwara M; Pérez A; Ricoy JR; Hernández-Laín A; Sepúlveda JM; Sánchez-Gómez P
    J Clin Invest; 2013 Jun; 123(6):2475-87. PubMed ID: 23635774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor and ligand family expression and activity in glioblastoma.
    von Achenbach C; Weller M; Szabo E
    J Neurochem; 2018 Oct; 147(1):99-109. PubMed ID: 29953622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.